Evidence map›Paper›PMID 37712644›Full record

ArticleEuropace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology2023

Comparison of in-hospital outcomes and complications of leadless pacemaker and traditional transvenous pacemaker implantation.

Majd Al Deen Alhuarrat, Amrin Kharawala, Sarath Renjithlal, Mohamed Magdi Eid, Dimitrios Varrias, Moghniuddin Mohammed, Michael Grushko, Luigi Di Biase

Open access · hybridAbstract read
In one paragraph

Article in Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 3 pooled it
8.1field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 3 syntheses or guidelines pooled it, 37 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Observational
  9. Long-term follow up of single-chamber atrial pacing-system upgrade and Wenckebach block point behavior: potential implications for leadless AAI pacing?Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing · 2025
    Article
  10. Comparison of readmission outcomes and complications between leadless and traditional transvenous pacemakers in older adults: a nationwide readmission analysis of 49852 admission events.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  11. Leadless vs. transvenous pacemakers following transcatheter aortic valve replacement: a dual-centre propensity score-matched observational study.Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology · 2025
    Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Majd Al Deen AlhuarratDivision of Internal Medicine, Jacobi Medical Center, Albert Einstein College Medicine, Bronx, NY, USA.ORCID 0000-0003-2016-1496
Amrin KharawalaDivision of Internal Medicine, Jacobi Medical Center, Albert Einstein College Medicine, Bronx, NY, USA.ORCID 0000-0003-3989-4489
Sarath RenjithlalDepartment of Internal Medicine, Rochester Regional Health/Unity Hospital, Rochester, NY, USA.ORCID 0000-0002-1969-0529
Mohamed Magdi EidDepartment of Internal Medicine, Rochester Regional Health/Unity Hospital, Rochester, NY, USA.ORCID 0000-0002-6102-479X
Dimitrios VarriasDivision of Internal Medicine, Jacobi Medical Center, Albert Einstein College Medicine, Bronx, NY, USA.ORCID 0000-0001-9778-1728
Moghniuddin MohammedDepartment of Cardiology, Rochester Regional Health, Rochester, NY, USA.ORCID 0000-0003-3614-4922
Michael GrushkoDivision of Internal Medicine, Jacobi Medical Center, Albert Einstein College Medicine, Bronx, NY, USA.
Luigi Di BiaseDivision of Cardiology, Montefiore Medical Center, Albert Einstein College of Medicine, 111 East 210th Street, Bronx, NY 10467, USA.ORCID 0000-0001-6508-4047
Albert Einstein College of Medicine · USUnity Health System · US

Funding

commercial
6 · The paper itself

Abstract

aimsSince their introduction in 1958, traditional cardiac pacemakers have undergone considerable upgrades over the years, but they continue to have a complication rate of ∼3.8%-12.4%. There are no randomized controlled trials comparing outcomes of leadless pacemakers (LPM) with single-chamber transvenous pacemakers (TV-VVI). The aim is to assess the differences in the procedural complications and in-hospital outcomes between LPM and TV-VVI implants. METHODS AND

resultsWe queried the national inpatient database from 2016 to 2019 to include adult patients undergoing LPM and TV-VVI. Admissions for leadless and single-lead transvenous pacemakers were identified by their appropriate ICD-10 codes. Complications were identified using ICD-10 codes that mostly represent initial encounter. The difference in outcomes was assessed using multivariable logistic regression and 1:1 propensity score matching between the two cohorts. Thirty-five thousand four hundred thirty expanded samples of admissions were retrieved of which 27 650 (78%) underwent TV-VVI with a mean age 81.3 ± 9.4 years and 7780 (22%) underwent LPM with a mean age of 77.1 ± 12.1 years. The LPM group had a higher likelihood of in-hospital mortality [adjusted odds ratio (aOR): 1.63, 95% CI (1.29-2.05), P < 0.001], vascular complications [aOR: 7.54, 95% CI (3.21-17.68), P < 0.001], venous thromboembolism [aOR: 3.67, 95% CI (2.68-5.02), P < 0.001], cardiac complications [aOR: 1.79, 95% CI (1.59-2.03), P < 0.001], device thrombus formation [aOR: 5.03, 95% CI (2.55-9.92), P < 0.001], and need for a blood transfusion [aOR: 1.54, 95% CI (1.14-2.07), P < 0.005]. The TV-VVI group had higher likelihood of in-hospital pulmonary complications [aOR:0.68, 95% CI (0.54-0.87), P < 0.002] and had a need for device revisions [aOR:0.42, 95% CI (0.23-0.76), P < 0.004].

conclusionThere is a higher likelihood of all-cause in-hospital mortality and complications following LPM implantation in comparison to TV-VVI. This could be related to higher co-morbidities in the LPM group. Clinical trials aimed to accurately compare these two groups should be undertaken.

Indexed as

Arrhythmias, CardiacPacemaker, ArtificialAdultAgedAged, 80 and overEquipment DesignHospitalsHumansPropensity ScoreTreatment OutcomeCardiac arrestLeadless pacemakerMortalityPericardial effusionTV-VVIVenous thromboembolism

Identifiers

PMID37712644
PMCPMC10517739
OpenAlexW4386757352

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.